Clinical trials
Recruiting Breast Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
447 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 6 |
| 2021 | 24 |
| 2022 | 37 |
| 2023 | 78 |
| 2024 | 90 |
| 2025 | 120 |
| 2026 | 76 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 447 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 48 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 28 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 19 |
| Sun Yat-sen University | 16 |
| Shengjing Hospital | 14 |
| Henan Cancer Hospital | 13 |
| The First Affiliated Hospital with Nanjing Medical University | 13 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 10 |
| Peking Union Medical College Hospital | 10 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 10 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 447 |
| Lung Neoplasms | 25 |
| Triple Negative Breast Neoplasms | 24 |
| Ovarian Neoplasms | 23 |
| Neoplasm Metastasis | 22 |
| Stomach Neoplasms | 20 |
| Carcinoma, Non-Small-Cell Lung | 17 |
| Pancreatic Neoplasms | 17 |
| Colorectal Neoplasms | 16 |
| Esophageal Neoplasms | 14 |
Trials
Showing 1 to 25 of 447. Each trial links to its page on Pharma Observatory.
347 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.